Autoimmunity in systemic lupus erythematosus: Integrating genes and biology

被引:31
作者
Krishnan, Sandeep [1 ]
Chowdhury, Bhabadeb [1 ]
Tsokos, George C. [1 ]
机构
[1] Walter Reed Army Inst Res, Dept Cellular Injury, Silver Spring, MD 20910 USA
关键词
SLE; autoimmunity; allelic variants; biomarkers; signal transduction;
D O I
10.1016/j.smim.2006.03.011
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Susceptibility to the autoimmune phenotype of systemic lupus erythematosus (SLE) is heritable. Linkage analysis and recent advances in the field of single nucleotide polymorphisms (SNPs) have resulted in the identification of several genetic loci and functional allelic variants of signaling proteins which have become the mainstay of understanding disease susceptibility and exploring the basis of autoimmunity in SLE. However, genetic heterogeneity and possible epistatic interactions among genetic elements have precluded replication of these findings in multiple population groups and thus complicated their interpretation. In this regard, the discovery that a plethora of normal signaling proteins are expressed in abnormal amounts in immune cells from patients with SLE has gained significance. Thus, the key to precise elucidation of the pathologic basis of autoimmunity in SLE lies in tying genetics and disease biology. This review highlights recent discoveries of important functional genetic variants and altered expression of normal signaling proteins that network together to disrupt peripheral tolerance and initiate the autoimmune process in SLE. (C) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:230 / 243
页数:14
相关论文
共 152 条
[1]   MCP-1 promoter polymorphism in Spanish patients with systemic lupus erythematosus [J].
Aguilar, F ;
González-Escribano, MF ;
Sánchez-Román, J ;
Núñez-Roldán, A .
TISSUE ANTIGENS, 2001, 58 (05) :335-338
[2]  
Alarcón-Riquelme ME, 2003, NAT GENET, V35, P299, DOI 10.1038/ng1203-299
[3]  
Alleva DG, 1998, J IMMUNOL, V161, P6878
[4]  
AMASAKI Y, 1995, CLIN EXP IMMUNOL, V99, P245
[5]   A Toll for lupus [J].
Anders, HJ .
LUPUS, 2005, 14 (06) :417-422
[6]   Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus [J].
Baechler, EC ;
Batliwalla, FM ;
Karypis, G ;
Gaffney, PM ;
Ortmann, WA ;
Espe, KJ ;
Shark, KB ;
Grande, WJ ;
Hughes, KM ;
Kapur, V ;
Gregersen, PK ;
Behrens, TW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (05) :2610-2615
[7]   New insights from murine lupus: disassociation of autoimmunity and end organ damage and the role of T cells [J].
Bagavant, H ;
Fu, SM .
CURRENT OPINION IN RHEUMATOLOGY, 2005, 17 (05) :523-528
[8]  
Barnes BJ, 2003, CANCER RES, V63, P6424
[9]   Inhibition of CTLA-4 function by the regulatory subunit of serine/threonine phosphatase 2A [J].
Baroja, ML ;
Vijayakrishnan, L ;
Bettelli, E ;
Darlington, PJ ;
Chau, TA ;
Ling, V ;
Collins, M ;
Carreno, BM ;
Madrenas, J ;
Kuchroo, VK .
JOURNAL OF IMMUNOLOGY, 2002, 168 (10) :5070-5078
[10]   Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases [J].
Becker, KG ;
Simon, RM ;
Bailey-Wilson, JE ;
Freidlin, B ;
Biddison, WE ;
McFarland, HF ;
Trent, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (17) :9979-9984